| HOME >> MEDICINE >> TECHNOLOGY |
246,443251,698Intangible assets, net
2,063,5632,118,948Goodwill
2,117,4852,108,847Other assets
52,88847,460$
5,665,579$
5,625,834LIABILITIES AND STOCKHOLDERS' EQUITYCURRENT LIABILITIES:Notes payable
$
,027$
,362Accounts payable
63,97657,480Accrued expenses
170,953183,054Deferred revenue
120,759120,516Deferred gain
79,50079,500Total current liabilities
436,215441,912Convertible notes (principal of $1,725,000)
1,434,1321,447,053Deferred income tax liabilities
956,627955,611Deferred service obligations- long term
10,75210,011Other long-term liabilities
73,83772,698Total long-term liabilities
2,475,3482,485,373STOCKHOLDERS' EQUITY:Common stock
2,6032,595Capital in excess of par value
5,269,1725,224,399Accumulated deficit
(2,516,130)(2,527,070)Accumulated other comprehensive (loss) income
(111)143Treasury stock, at cost
(1,518)(1,518)Total stockholders' equity
2,754,0162,698,549$
5,665,579$
5,625,834HOLOGIC, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(Unaudited)(In thousands, except per share data)Three Months EndedDecember 25, 2010December 26, 2009REVENUES Product sales
$
358,603$
351,410Service and other revenues
73,96861,038432,571412,448COSTS AND EXPENSES (1):Cost of product revenues
125,025114,751Cost of product revenues – amortization of intangible assets
42,11243,520Cost of service and other revenues
40,70037,732Research and development
28,55724,621Selling and marketing
67,91164,597General and administrative
40,45341,192Amortization of intangible assets
14,49613,579Contingent consideration fair value adjustment
1,096-Restructuring and other charges
501487360,851340,479Income from operations
71,72071,969Interest expense
(28,909)(31,804)Other
'/>"/>
| SOURCE Hologic, Inc. Copyright©2010 PR Newswire. All rights reserved |